Antidepressants and Violence: Problems at the Interface of Medicine and Law_PLoS
Evidence of an association between violence and widely prescribed antidepressant drugs is the focus of this Infomail.
Evidence of an association between violence and widely prescribed antidepressant drugs is the focus of this Infomail.
USA Today reports that last year the pharmaceutical industry "faced the most product liability lawsuits of any other industry."
An editorial in today's New York Times is a follow-up to its riveting report by Ian Urbina on the recommendation by an Institute of Medicine panel to
lift 1978 federal restrictions on medical experiments on prisoners. http://www.nytimes.com/2006/08/13/us/13inmates.html?
The verdict is th fourth multi-million dollar loss for Merck in Vioxx litigation.
Every federal oversight agency evaluating FDA’s safety performance has given the agency flunking grades. See:https://ahrp.org/cms/content/view/148/55/
The New York Times reports that a Maryland psychiatrist, Dr. Peter Gleason, was handcuffed and arrested in March and charged with criminal promotion of a drug "for purposes other than those approved by the federal government."
Bloomberg News reports (below) that Senator Charles Grassley has asked the Inspector General to investigate collusion between FDA officials and Merck. Citing handwritten notes prepared by a Merck executive document a meeting with FDA division director, Brian Harvey, suggesting a joint effort "to get the message out" to discredit Dr….
CYBERONICS ANNOUNCES MECHANISM OF ACTION ADVISORY BOARD
Following on the heels of an investigative report by David Armstrong of The Wall Street Journal <https://ahrp.org/cms/content/view/286/27/> the Associated Press reports that JAMA claims it was misled.
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Two documented news reports provide evidence validating our charge that FDA officials and drug manufacturers.
A documented report by David Armstrong of The Wall Street Journal (below) shatters the last glimmer of illusion about The New England Journal of Medicine as a bastion of scientific and moral integrity.